Tan X, Liang Y, Xie L, Harton J, et al. Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States. Diabetes Obes Metab 2026 Jan 8. doi: 10.1111/dom.70440.
PMID: 41508706